| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/14/1997 | EP0773289A2 Asialoglycoprotein receptor derivatives and their use |
| 05/14/1997 | EP0773287A1 Immortalised embryonic hyppocampal cells and their use |
| 05/14/1997 | EP0773228A1 Method of producing human monoclonal antibodies and their use |
| 05/14/1997 | EP0772691A1 Vectors and transformed host cells for recombinant protein production at reduced temperatures |
| 05/14/1997 | EP0772634A1 Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications |
| 05/14/1997 | EP0772632A2 T cell stimulating protein of pestivirus |
| 05/14/1997 | EP0772627A1 Production of biologically active recombinant neurotrophic protein |
| 05/14/1997 | EP0772624A1 Interleukin-15 |
| 05/14/1997 | EP0772437A1 Compositions and methods for delivery of genetic material |
| 05/14/1997 | EP0772399A1 Mixtures of genetically modified insect viruses with chemical and biological insecticides for enhanced insect control |
| 05/14/1997 | EP0677111B1 Novel proteinaceous particles |
| 05/14/1997 | EP0640145B1 Measurement of an enzyme marker as an aid to diagnosis |
| 05/14/1997 | EP0441947B1 Neurotrophin-3, a novel neurotrophic factor related to nerve growth factor and brain derived neurotrophic factor |
| 05/14/1997 | CN1149889A Isolated nucleic acid molecule with codes for tumor rejection antigen precursor and uses thereof |
| 05/14/1997 | CN1149887A Compounds and methods for stimulation and enhancement of protective immune responses and IL-12 production |
| 05/14/1997 | CN1149627A Reagent peptone formula and its producing technology |
| 05/13/1997 | US5629469 Peptide virgiferin and variations; recombinant dna molecule with nucleic acid sequence encoding peptide; transgenic plant with foreign gene encoding peptide; combatting insects with peptide; host cell transformed with vector as described |
| 05/13/1997 | US5629205 Promoters for gene expression |
| 05/13/1997 | US5629204 Peptide related to human programmed cell death and DNA encoding it |
| 05/13/1997 | US5629193 Paraoxonase |
| 05/13/1997 | US5629176 Dna construct comprising dna sequence encoding the variant; recombinant expression vector comprising the construct; host cell containing the construct or vector; culture process for making the variant; pharmaceutical comprising the variant |
| 05/13/1997 | US5629175 Molecular farming |
| 05/13/1997 | US5629174 Dna, rna |
| 05/13/1997 | US5629173 Methods of use of serine protease variants having peptide ligase activity |
| 05/13/1997 | US5629172 Ubiquitin molecule is cleavage site |
| 05/13/1997 | US5629167 Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay |
| 05/13/1997 | US5629165 Calpastatins, detection of neurodegenerative conditions such as alzheimer*s disease by reaction with antibody |
| 05/13/1997 | US5629161 Use of human papillomavirus gene derived peptides for diagnosis |
| 05/13/1997 | US5628996 Method for inhibiting the viability of Pseudomonas aeruginosa with cross-reactive and cross-protective monoclonal antibodies |
| 05/09/1997 | WO1997016549A2 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 05/09/1997 | WO1997016541A1 Alkaline protease, process for the production thereof, use thereof, and microorganism producing the same |
| 05/09/1997 | WO1997016538A1 (-)-strand rna virus vector having autonomously replicating activity |
| 05/09/1997 | WO1997016532A1 Immunity against actinobacillus pleuropneumoniae's rtx toxins apx |
| 05/09/1997 | WO1997016531A1 Immunity against pasteurella haemolytica leukotoxin |
| 05/09/1997 | WO1997016530A1 New e.coli mutant with suppressed organic acid production |
| 05/09/1997 | WO1997016461A1 Monoclonal antibody specific for prostaglandin d synthetase |
| 05/09/1997 | WO1997016457A2 Anti-tumoral protein |
| 05/09/1997 | WO1997016439A1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/09/1997 | WO1997016206A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 05/09/1997 | WO1997016064A1 Methods and compositions for the reduction of xenotransplantation rejection |
| 05/09/1997 | WO1997012039A3 Sh2-containing inositol-phosphatase |
| 05/09/1997 | WO1996034885A3 Biologically active peptide fragments of ob protein |
| 05/09/1997 | CA2236297A1 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 05/09/1997 | CA2209314A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 05/09/1997 | CA2208871A1 New e.coli mutant with suppressed organic acid production |
| 05/08/1997 | CA2189499A1 Immortalised embryonic hippocampal cells and their use |
| 05/07/1997 | EP0771875A1 Porcine CNP gene and precursor protein |
| 05/07/1997 | EP0771871A2 Expression of human serum albumin in methylotrophic yeasts |
| 05/07/1997 | EP0771358A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof |
| 05/07/1997 | EP0771352A1 Lkp pilin structural genes and operon of nontypable haemophilus influenzae |
| 05/07/1997 | EP0771351A1 Surface protein of staphylococcus aureus |
| 05/07/1997 | EP0771327A1 Contraceptive vaccine |
| 05/07/1997 | EP0771325A1 Process for modifying the stability of antibodies |
| 05/07/1997 | EP0771215A1 Retroviral transduction of cells using soluble complement inhibitors |
| 05/07/1997 | EP0771213A1 Haemophilus adherence and penetration proteins |
| 05/07/1997 | EP0771212A1 Contraceptive vaccine |
| 05/07/1997 | EP0771210A1 TWO NON-CONTIGUOUS REGIONS CONTRIBUTE TO NIDOGEN BINDING TO A SINGLE EGF-LIKE MOTIF OF THE LAMININ $g(g)1 CHAIN |
| 05/07/1997 | EP0771208A1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 05/07/1997 | EP0771192A1 Use of anti-vegf agents in the treatment of endometriosis |
| 05/07/1997 | EP0670907B1 Preventing endogenous aminopeptidase mediated n-terminal amino acid cleavage during expression of foreign genes in bacteria |
| 05/07/1997 | EP0652957B1 Assembled viral particles and their use in a vaccine to rotaviral disease |
| 05/07/1997 | EP0612217B1 Bacillus thuringiensis isolates active against cockroaches and genes encoding cockroach-active toxins |
| 05/07/1997 | EP0566571B1 Diagnosis of metastatic cancer by the mts-1 gene |
| 05/07/1997 | EP0515554B1 Method for generating and screening useful peptides |
| 05/07/1997 | EP0464155B1 Endothelial cell growth factor, isolation and expression |
| 05/07/1997 | DE19540902A1 Protein mit Anti-Tumorwirkung Protein with anti-tumor activity |
| 05/07/1997 | CN1149319A Angiostatin and method of use for inhibition of Angiogenesis |
| 05/07/1997 | CN1149317A DNA sequences |
| 05/07/1997 | CN1149299A Anti-GP39 antibodies and uses therefor |
| 05/07/1997 | CN1149258A Inhibin compositions and methods of use thereof |
| 05/07/1997 | CN1149257A Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
| 05/07/1997 | CN1148984A Process for preparing pharmaceutical formulation containing insulin analog |
| 05/06/1997 | US5627274 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 05/06/1997 | US5627267 Cytokine designated elk ligand |
| 05/06/1997 | US5627264 Chimeric complement inhibitor proteins |
| 05/06/1997 | US5627155 Controlling diseases with proteins such as allergies, psoriasis, tissue rejection and autoimmune diseases |
| 05/06/1997 | US5627153 Anti-fungal methods and materials |
| 05/06/1997 | US5627073 Hybridomas producing antibodies to cardiac hypertrophy factor |
| 05/06/1997 | US5627067 Monoclonal antibodies cross-reactive and cross-protective against human monoclonal antibodies against pseudomonas aeruginosa serotypes |
| 05/06/1997 | US5627050 Bone-related sulfatase-like protein and process for its production |
| 05/06/1997 | US5627049 Isolated dna sequence from kluyveromyces |
| 05/06/1997 | US5627046 Yeast promoter and its use |
| 05/06/1997 | US5627044 Compositions and methods for protein structural determinations |
| 05/06/1997 | US5627023 Enzyme inhibitors for treatment of aids, cell culture and genetic engineerng |
| 05/02/1997 | EP0770681A2 T cell epitopes of the major allergens from ambrosia artemisiifolia |
| 05/02/1997 | EP0770680A2 Lymphocyte-associated cell surface protein |
| 05/02/1997 | EP0770628A1 Reconstituted human antibody against human interleukin-8 |
| 05/02/1997 | EP0770396A2 Use of new factor VIII coagulant polypeptides |
| 05/02/1997 | EP0770141A1 INTERLEUKIN-1 $g(b) CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-1 AND 2 |
| 05/02/1997 | EP0770139A1 A FUNGUS WHEREIN THE areA GENE HAS BEEN MODIFIED AND AN areA GENE FROM ASPERGILLUS ORYZAE |
| 05/02/1997 | EP0770138A2 Mycobacteria functional screening and/or expression vectors |
| 05/02/1997 | EP0770137A1 Improvements in production of proteins in host cells |
| 05/02/1997 | EP0770136A1 Method for selecting high-expressing host cells |
| 05/02/1997 | EP0770135A1 Novel compounds |
| 05/02/1997 | EP0770132A1 Streptogramines and method for preparing same by mutasynthesis |
| 05/02/1997 | EP0770129A1 Zinc finger protein derivatives and methods therefor |
| 05/02/1997 | EP0770126A1 Granular formulation containing microorganisms, a process for the preparation and the use thereof |
| 05/02/1997 | EP0770093A1 Proteins from mammalian liver and their use in oncology |
| 05/02/1997 | EP0770089A1 Growth differentiation factor-12 |
| 05/02/1997 | EP0770088A1 Novel cytokine designated lerk-5 |